Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study designed to evaluate the company’s non ...

Scientists reverse eye cell aging with ER-100 gene therapy that reprograms retinal neurons to younger states, offering hope ...

A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...

Ginkgo Bioworks says a new AI collaboration with OpenAI is already paying off, cutting the cost of protein production in the lab by a mea ...

It had been thought that AI would play a big part in digital-only domains like math and coding, but cleverly connecting these ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

Walk into any drugstore and you'll see shelves stacked with bottles promising better health. Millions of people pop vitamins ...

We vet the latest Korean beauty trend.

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

During the fifth day of searching for Nancy Guthrie, Pima County Sheriff Chris Nanos said he believes technology will be ...

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

Revenue of $1.16 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)Ex-China revenue of $1.10 billion, up 8% from ...